A detailed history of Sofinnova Investments, Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 825,243 shares of KURA stock, worth $15.9 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
825,243
Previous 501,940 64.41%
Holding current value
$15.9 Million
Previous $10.7 Million 58.71%
% of portfolio
0.94%
Previous 0.62%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$17.53 - $22.98 $5.67 Million - $7.43 Million
323,303 Added 64.41%
825,243 $17 Million
Q1 2024

Aug 14, 2024

SELL
$13.42 - $23.53 $4.34 Million - $7.61 Million
-323,303 Reduced 39.18%
501,940 $10.7 Million
Q1 2024

May 15, 2024

SELL
$13.42 - $23.53 $15.6 Million - $27.4 Million
-1,165,381 Reduced 69.9%
501,940 $10.7 Million
Q4 2023

Aug 15, 2024

BUY
$7.58 - $14.38 $6.38 Million - $12.1 Million
842,078 Added 102.04%
1,667,321 $24 Million
Q4 2023

Feb 12, 2024

BUY
$7.58 - $14.38 $12.6 Million - $24 Million
1,667,321 New
1,667,321 $24 Million
Q1 2023

May 11, 2023

BUY
$10.71 - $14.6 $242,131 - $330,076
22,608 Added 3.81%
616,169 $7.54 Million
Q4 2022

Feb 13, 2023

BUY
$11.23 - $16.9 $6.67 Million - $10 Million
593,561 New
593,561 $7.37 Million
Q1 2022

May 16, 2022

SELL
$11.78 - $16.98 $4.35 Million - $6.27 Million
-369,173 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$12.22 - $19.57 $4.72 Million - $7.55 Million
-385,948 Reduced 51.11%
369,173 $5.17 Million
Q3 2021

Nov 15, 2021

BUY
$15.42 - $21.72 $4.79 Million - $6.75 Million
310,749 Added 69.93%
755,121 $14.1 Million
Q2 2021

Aug 16, 2021

BUY
$20.85 - $29.88 $7.53 Million - $10.8 Million
361,208 Added 434.33%
444,372 $9.27 Million
Q1 2021

May 14, 2021

SELL
$24.75 - $39.14 $928,446 - $1.47 Million
-37,513 Reduced 31.09%
83,164 $2.35 Million
Q4 2020

Feb 16, 2021

SELL
$29.0 - $41.62 $3.03 Million - $4.35 Million
-104,582 Reduced 46.43%
120,677 $3.94 Million
Q3 2020

Nov 13, 2020

SELL
$16.3 - $30.64 $6.29 Million - $11.8 Million
-385,720 Reduced 63.13%
225,259 $6.9 Million
Q2 2020

Aug 13, 2020

BUY
$7.95 - $18.81 $4.86 Million - $11.5 Million
610,979 New
610,979 $9.96 Million
Q4 2018

Feb 14, 2019

SELL
$10.6 - $17.49 $2.62 Million - $4.33 Million
-247,385 Closed
0 $0
Q3 2018

Nov 15, 2018

BUY
$16.65 - $21.85 $1.32 Million - $1.74 Million
79,485 Added 47.34%
247,385 $4.33 Million
Q2 2018

Nov 15, 2018

BUY
$14.8 - $18.8 $2.23 Million - $2.83 Million
150,605 Added 870.8%
167,900 $3.06 Million
Q2 2018

Aug 14, 2018

BUY
$14.8 - $18.8 $255,966 - $325,146
17,295 New
17,295 $315,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $1.29B
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.